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EDITORIALS 
Components of the Cellular Cytoskeleton: 
A New Generation of Markers of Histogenetic Origin? 
Histology and pat hology are based on t he fact that many cell 
types can be distinguished by different forrl?s of ~icroscopy. ~ 
s urprising number of cell types can be 1dent1fied by the1r 
m o rphology in t he light microscope after staining with common 
stai n s such as hematoxylin-eosin or Giemsa. Other special 
stains applied wi th protocols often evolved by trial and error 
many decades ago serve to further ident ify specific cell types. 
With the advent of immuncytochemical techniques using con-
ventiona l a ntibodies, and more recently monoclonal a ntibodies, 
the possibilities for in situ identification of diffe rent cell types 
have been greatly increased. Such techniques a llow cell lineages 
to be traced and yield information t hat can be of practical 
importance in deal ing with benign or malignant lesions. Three 
types of markers will be considered here: intermediate fil a -
ments, desmoplakins, and involucrin . 
INTERMEDIATE FILAMENTS 
Intermediate fil aments (IF) are a major fibrous component 
of t h e cytoskeleton of almost a ll vertebrate cells and have a 
diameter of 7-11 nm in t he electron microscope. IF typing, i.e., 
determination of the type of IF present in a particular cell type 
y ields information relevant to the histogenetic origin _o~ ~he 
celL Epithelial IFs include the keratms of both keratn~1zmg 
a nd nonkeratinizing epithelia as well as t he hard a- keratms of 
wool and hair. Nonepit helial IF proteins include neurofila ments 
characteristic of most but not all neurones, desmin 
(Greek:bwJLOIT == link) , a ma rker of most muscle cell different ia-
tions, glial fibrillary ac idic protein (GFA) found i~ astrocytes 
and Bergmann glia cells, and vimentin (Latm: v1mentum = 
arr ays of flexible rods), the only IF present in cell types s_uch 
as fibroblasts, endotheli a l cells, etc. A few well-charactenzed 
ce ll types can coexpress vimentin IFs and one other IF type, 
and in a fe w other cell types in termediate filaments appear not 
to be present. This division of IFs into different groups was 
originally made by immunologic techniques. Mor_e recent stud-
ies in which the sequences of different IF protems have been 
determined either by amino acid sequence studies (e.g., [1 ,2]) 
or by DNA sequencing studies (e.g., [3,4)) have firmly estab-
lished t hat IFs are a multigene fa mily of different but related 
proteins. Moreover they have revealed t hat t he protofi lamen_ts 
of a ll members of t his fam ily share a common structural motif, 
i e a central rod a-helical coiled-coil domain of approximately 
4o-kd flanked on eit her side by head and tail regions of variable 
lengths which are non-a-helical in nature. Presumably it is the 
common rod portion t hat is responsible for the common prop-
erties shared by all IFs, i.e., ultrastructure and morphology, 
insolubility in normal buffers, and reconstitut ion in vit ro from 
the purified proteins. T wo of t he IF groups contain mult ip_le 
polypept ides. The first of t hese, t he neurofilaments, co~tam 
three different polypeptides of apparent molecular wetghts 
68,000, 160,000, and 200,000. All t hree neurofilament polypep-
tides contain t he common rod domain toward t he aminoter-
minal end, suggesting t hat a ll three polypeptides are incorpo-
rated into t he backbone of t he filament [2]. It seems possible 
that t he specificity of Bodian si lver stain for all three neurofi -
lament polypeptides [5] resides in the sequences present in t he 
carboxytermina l tailpieces [2] . The second IF group which 
contains multiple polypept ides comprises the epithelial kera-
t ins. Here at least 19 different keratin polypeptides are found 
in the human with apparent molecular weights ranging between 
40,000 and 68,000. Different epit helia contain different subsets 
of keratins and t hese have been catalogued [6,7]. Examination 
of such catalogues shows that the kerat in composition varies 
depending on a variety of factors including epithelial cell type 
and state of histologic differentiation. From t he emerging se-
quence and hybridization data it appears possible to subdivide 
t he keratins into t wo subfamilies, I and II. A complementary 
interaction between t hese two prototypes would explain t he 
known obligatory heteropolymer formation (4]. The number of 
polypeptides per 10-nm filament could be in the order of 24-36 
and current models favor double-stranded rather than triple-
stranded coiled-coils. 
Monoclonal ant ibodies specific for desmin, vimentin , GFA, 
and each of t he neurofilament polypeptides have been isolated 
(e.g., [8,9)) . Monoclonal a nt ibodies specific for keratin are of 
part icular interest because of the possibility of subdividing 
epit helia according to t heir keratin content by immunologic 
methods. Thus both broad-specificity monoclonal keratin an-
tibodies recognizing many different cytokeratin polypeptides 
and monoclonal antibodies recogn izing only one or a few ker-
atin polypeptides have been described (10-13). Examples of the 
latter group include monoclonal antibodies specific for a single 
keratin polypeptide which can distinguish simple from squa-
mous epithelia [11,12], as well as monoclonal antibodies which 
distinguish different cell layers within human epidermis [13). 
Both t he convent ional and the monoclonal antibodies to IFs 
can be used to characterize not only cells in normal tissues but 
also in pathologic material. Several t housand t umors have been 
examined by t he combined effort of different groups in indirect 
immunofluorescence microscopy using such antibodies. The 
resul ts (for review and original references see [14)) demonstrate 
that in solid tumors the IF type characteristic of the cell of 
origin is reta ined, or to state it in a different form that carci-
nomas di splay keratin; muscle sarcomas, i.e. leiomyosarcoma 
and rhabdomyosarcoma contain desmin; astrocytoma, and 
gliomas GFA; certain tumors of neural origin such as gangli -
oneurob lastoma and pheochromocytoma contain neurofila-
ments; while non- muscle sa rcomas, lymphomas, solid leukemia, 
and me lano mas contai n only vimentin . It should be noted that 
alt hough vimentin is generally considered as a marker of cells 
of mesenchymal origin it can also be p resent in other cell types. 
Thus, for instance, a few epithelial cell types as well as a few 
t umors such as pleomorphic adenoma appear to coexpress 
keratin and vimentin. It is a lready clear t hat IF typing can be 
very informative in certain instances which are hard to char-
acterize by conventional methods, e.g., to distinguish the small 
round cell tumors of children, to distinguish lymphoma vs 
carcinoma, or to help in classification of cytologic specimens. 
Studies using certain keratin monoclonal ant ibodies suggest 
that a further subdivision of carcinomas is possible using im-
munologic techniques. For instance the CK1- CK4 group, RGE 
53, and LE61 recognize tumors derived from simple epithelia 
but do not recognize most squamous carcinomas [11 ,15,16]. 
Other keratin monoclonals have been used to demonstrate 
changes in keratin expression in human epidermal disease [ 17] 
. The resul ts with tumor material demonstrate very clearly that 
IF typing is of value in surgical pathology, and its use in cases 
where a decision has to be made between morphologically 
similar cell types of different histogenetic origin can be expected 
to increase. 
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DESMOPLAKINS 
Desmosomes are one type of cellular junction abundantly 
present in epit helial cells and distinguished by t heir character-
istic ultrastructure in t he electron microscope. Keratin fila-
ments run to desmosomal plaques present on the cytoplasmic 
surface of the plasma membrane of two neighboring cells . An 
intercellular core is visible between t he two cells and charac-
terizes the desmosome structure. Desmosomes are usually pur-
ified from cow snout and t he polypeptide composit ion has been 
determined (18- 20]. The proteins associated with t he desmo-
somal p laques include two polypeptides with apparent molec-
ular weights of 250,000 and 215,000 which are major constitu-
ents of the plaque and to which t he names desmoplakin I and 
II have been given (G reek: OHJJ.J.OU = link; 7rAaKou = plaque) 
[19]. Conventional antibodies to desmoplakins can be used to 
identify desmosomes in situ in epithelial t issues from cow and 
human using indirect immunofluorescence microscopy (19]. If 
the section is sufficiently thin desmosomes are visualized as 
rows of dots at the plasma membranes of adjoining cells. 
Isolation of the constituents of the intercellular desmosomal 
core results in enrichment of several glycoprotein families with 
apparent mo lecular weights of 150,000, 97,000- 118,000, and 
22,000 [20]. Monoclonal antibodies to the two higher-molecu-
lar-weight fam ilies have been isolated but immunofluorescence 
results with these monoclonals have so far been restricted to 
cow snout epidermis [21] . 
Tumors of epithelial origin seem clearly positive with des-
moplakin antibodies, as shown by studies using frozen sections 
[19]. Tumors tested include basal cell epithelioma; squamous 
cell carcinoma of skin, tongue, epiglottis, esophagus, cervix, 
and rectum; carcinoma of the stomach and colon; and hepato-
cellular carcinoma. Metastases of epithelial origin also retain 
desmoplakins. Staining is visualized usually as a series of dots 
at the boundary between tumor cells, which in certain tumors 
such as adenocarcinoma of stomach and colon may show apical 
enrichment. Cells in the stroma are unstained by desmoplakin 
antibodies. 
Although , in general, desmoplakin antibodies are valid mark-
ers identifying both normal and malignant epithelial cells, a 
few other specialized cell types in which desmosomes can be 
distinguished ultrastructurally also react positively with des-
moplakin antibodies. In myocardial cells and Purkinje fiber 
cells, desmin rather than keratin filaments are found in asso-
ciation with the desmosomes. In addition, in arachnoidal cells 
and meningiomas, vimentin filaments are associated with the 
desmosomes [22]. Thus these additional cell types have to be 
taken into account when desmoplakin antibodies alone are used 
to assess histogenetic origin. The finding that a cell is positive 
for both desmoplakin and keratin, however, would appear to 
classify it as being of epithelial origin. 
INVOLUCRIN 
lnvolucrin (Latin: involucrum = envelope), a 92,000 molec-
ular weight protein , is a soluble precursor protein of the enve-
lope of stratified squamous ep ithelial cells [23]. Isolated from 
human epidermal keratinocytes growing in culture where it 
comprises 5- 10% of t he so luble cell protein, it has been shown 
to act as substrate for the t ransglutaminase-catalyzed reaction 
leading to envelope formation. This reaction is calcium-de-
pendent and results in the inco rporation of involucrin, and also 
other proteins [24,25] into the cross- linked envelope visualized 
as a 10- to 12-nm marginal band in mature squamous epithelial 
cells after osmication. Investigation of the distribution of in -
volucrin in different human t issues [23,26] has shown t hat it is 
present in a ll strat ified squamous epithelia irrespective of 
whether or not they contain a stratum corneum. In human 
epiderm is, involucrin is not present in t he deepest layers but is 
found in cells of the outer ha lf of the stratum spinosum and in 
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the stratum granulosum. When first detected, involucrin is 
present throughout the cytoplasm, but t hen as the cell matures 
it becomes concentrated at the cell periphery prior to becoming 
cross-linked at t he site of stratum corneum formation. Other 
human stratified squamous epit helia, i.e., t hose from conjunc-
t iva, cornea, to ngue, esophagus, and vaginal ep it helia show 
approximate ly equivalent distributions of involucrin , i.e ., no 
staining is seen in t he basal layer and in adjacent layers of the 
epit helium. The point in t he epit helium at which involucrin 
staining is first detected can in some instances be correlated 
with t he boundary between zones of large and small cells visible 
in phase microscopy. 
In t his issue of t he Journal two groups report on the distri-
bution of involucrin in squamous cell carcinoma and in basal 
cell epithelioma. For squamous cell carcinoma in situ Said et 
al (27) report in eight cases a diffuse staining on involucrin in 
a ll cell layers of the neoplastic epidermis down to t he basal 
layer and in three cases focal staining of nests of dyskeratotic 
cells. Murphy et al [28) report six cases and illustrate one case 
in which nests of dyskeratotic cells are clearly discernible. For 
squamous cell carcinoma of the invasive type t here appears to 
be some disagreement. Said et al describe 13 cases with diffuse 
cytoplasmic staining of all layers of the epidermal components 
as well as of the infiltrating components, while Murphy et al 
describe three cases where the upper half of two-th irds of t he 
epidermis is positive and the invasive lobules are negative. 
Perhaps the easiest way to explain t he data is to assume that 
the program of different iation fo llowed by t he normal keratin-
ocyte is disturbed in squamous cell carcinoma, and, as might 
be expected from the patterns of involucrin expression in 
normal tissues, that the further the keratinocyte has progressed 
along its normal developmental pathway the more likely it is 
to express involucrin . For basal ce ll carcinoma, Sa id et al report 
21 cases and Murphy et al report t hree cases, all of which were 
negative for involucrin except for rare areas of squamoid dif-
ferentiation . Although Said et al state that this result is ex-
pected since the basal cells in the epidermis lack involucrin, 
neit her group conside rs t he natural distribution of this tumor 
in detail. Basal cell epithelioma occurs predominantly on t he 
face and scalp and rarely on the palms, soles, or mucous 
membranes, suggesting that th is tumor may arise from cells of 
the hair fo llicles. In this connection results in which the kera-
t ins present in basal cell epit helioma have been characterized 
by gel electrophoresis are of interest [29,30]. The keratin pro-
tiles of basal cell epithe lioma have also been shown to be very 
similar to t hat of the pilosebaceous tract, a nd, in particular, 
using microdissection, to that of the external root sheath epi-
thelium of the lower part of t he follicle [30]. T hus Moll et al 
have suggested t hat basal cell epitheliomas might originate 
either from t hese cells, or from relatively rare basal epidermal 
cells developing some features of differentiation in common 
with cells of the pilosebaceous t ract. The finding of Murphy et 
al [28] that cells of the external root sheath epit helium are 
negative for involucrin would not contradic t such a hypothesis. 
Perhaps evidence further delineating t he cell type of origin of 
this tumor can be obtained using monoclonal antibodies specific 
for one or other of the keratin polypeptides present in this 
tumor. Other material t hat has been examined wit h antibodies 
to involucrin includes cervicovaginal lesions [31] as well as a 
variety of lung tumors [32]. In t he latter study all squamous 
and adenosquamous carcinomas studied showed posit ive stain-
ing, suggesting t hat in th is t issue also involucrin is a specific 
marker for squamous cell differentiation. Parallel staining of 
tumor specimens with involucrin antibodies and with keratin 
antibodies recognizing only one or more keratins characteristic 
of squamous cell differentiation would be of interest. Because 
of the necessary restriction of involucrin to a limited group of 
tumors, involucrin antibodies are unlikely to find so widespread 
an application in surgical pathology as IF or desmoplakin 
antibodies. 
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CONCLUSIONS 
The markers discussed here- intermediate filaments, des-
rnoplakins, and i~wolucrin-are a ll components of: particular 
types of diffe.rentiated cells, and a ll.were first descnbed m cell 
biologic studies. They are a lso maJOr protem constituen ts of 
the cytoplasm and can in a ll three cases be associated with an 
identifi able cellular structure. In each case the proteins can be 
isolated in amounts sufficient so that t hey can be c haracterized 
at the protein chemical level and a lso immunologically. Their 
cell type-specific expression patterns a re differe n t. Thus a ll 
cells can be ass igned to one or other of t h e classes defined by 
IF typ ing described above, and expression of a particular IF 
protein appears to be a relatively early step in the commitmen t 
of a cell to a particular developmental pathway. Desmoplakin 
expression is usually limited to cells of epit helia l o rigin and in 
such cells clearly parallels keratin expression. lnvolucrin 
expression is restricted to a yet more. limite? set of epithelial 
cells occurring o nly at a particular pomt dunng squamous cell 
differentiation. 
The results summarized above show that t hese markers can 
be used to type not on ly normal cells in s itu but also cells in 
neoplasms and other diseased states. So far the results suggest 
t hat as a general rule, t he neoplastic cells continue to express 
the ~ytoske leta l markers of the cell type from which the t umor 
ori crinates and t hus these markers provide information re levant 
to the histogenetic origin of the tumor. C learly the most appro-
priate use for s uch markers in pathology is to apply them in 
situations where they either (a) yield information about the 
oricrin of a particular t umor which m ay have been previously 
co;troversial, or (b) make a distinction which is of value to the 
patient, i.e., where the correct diagnosis is it;tport~nt either f~r 
t he treatment of t he disease or for prognosis. With the appli-
cation of t hese and other novel markers in routine surgical 
pathology and in cytology, imprecise terms sometimes used to 
describe tumors such as pleomorphic, round cell, or anaplast ic 
may be eliminated in many instances an.d in the diagn~~is of 
some fraction of the 2-5% of tumors difficult to classify by 
convention a l methods can be improved. 
Mary Osborn , Ph.D. . 
Max P lanck Institute for B iophysical C hem i try 
Goettingen, Federa l R epublic of Germany 
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